Paper Review Records
全部论文审稿周期
25 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
26
天
The case for targeting enhancer regions in high‐risk TCF3::HLF‐positive B‐cell acute lymphoblastic leukemia
作者
Zahra Sheybani; Charles E. de Bock展开收起
作者单位
1. Children's Cancer Institute Minderoo Children's Comprehensive Cancer Centre Randwick New South Wales Australia; 2. School of Clinical Medicine, Faculty of Medicine UNSW Sydney Sydney New South Wales Australia展开收起
78
天
Validation of the new IMS/IMWG consensus genomic staging (CGS) of high‐risk multiple myeloma (HRMM) in a contemporary cohort of 1209 patients
作者
Efstathios Kastritis; Charalampos Filippatos; Maria Gavriatopoulou; Foteini Theodorakakou; Eirini Solia; Ioannis Ntanasis‐Stathopoulos; Panagiotis Malandrakis; Nikolaos Kanellias; Evangelos Eleutherakis‐Papaiakovou; Magdalini Migkou; Vasiliki Spiliopoulou; Ilias Katsadouros; Aikaterini Vlachou; Despina Fotiou; Konstantinos Giannakas; Erasmia Boutakoglou; Stavroula Giannouli; Panagiotis Tsirigotis; Asimina Papanikolaou; Evangelos Terpos; Meletios A. Dimopoulos展开收起
作者单位
1. Department of Clinical Therapeutics, Alexandra General Hospital National and Kapodistrian University of Athens Athens Greece; 2. 2nd Department of Internal Medicine, “Hippokration” General Hospital National and Kapodistrian University of Athens Athens Greece; 3. 2nd Department of Internal Medicine ATTIKON General University Hospital, Hematology Division, National and Kapodistrian University of Athens Athens Greece; 4. Department of Haemopathology “Evangelismos” Hospital Athens Greece展开收起
83
天
First‐line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma
作者
Umberto Vitolo; Lorenzo Falchi; Per‐Ola Andersson; Marcel Nijland; Fritz Offner; Sylvia Snauwaert; Jacob H. Christensen; Michael R. Clausen; Alexander Fosså; Pilar G. Prieto; Eliza A. Hawkes; Judit M. Jørgensen; Yasmin H. Karimi; Catharina Lewerin; Joost S. P. Vermaat; Björn E. Wahlin; Poliana Patah; Christopher Morehouse; Malene Risum; Zhu Li; Jennifer Marek; Joshua D. Brody展开收起
作者单位
1. Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia‐IRCCS Candiolo (Turin) Piedmont Italy; 2. Lymphoma Service, Memorial Sloan Kettering Cancer Center New York New York USA; 3. Section for Hematology and Coagulation Sahlgrenska University Hospital Gothenburg Sweden; 4. Department of Hematology University Medical Center Groningen and University of Groningen Groningen Netherlands; 5. Department of Hematology Universitair Ziekenhuis Gent Ghent Belgium; 6. Department of Hematology AZ Sint‐Jan Hospital Bruges Belgium; 7. Department of Hematology Odense University Hospital Odense Denmark; 8. Department of Hematology and University of Southern Denmark Vejle Hospital Vejle Denmark; 9. Department of Oncology Oslo University Hospital Oslo Norway; 10. Department of Hematology IdiPaz, La Paz University Hospital Madrid Spain; 11. Olivia Newton John Cancer Research Institute at Austin Health Melbourne Victoria Australia; 12. Department of Haematology Aarhus University Hospital Aarhus Midtjylland Denmark; 13. Division of Hematology‐Oncology, Department of Medicine University of Michigan Ann Arbor MI USA; 14. Department of Hematology and Coagulation, Sahlgrenska University Hospital University of Gothenburg Gothenburg Götaland Sweden; 15. Department of Hematology Leiden University Medical Center Leiden Zuid‐Holland Netherlands; 16. Department of Hematology Karolinska Institutet Stockholm Stockholms län Sweden; 17. AbbVie North Chicago Illinois USA; 18. Genmab Plainsboro New Jersey USA; 19. Genmab Copenhagen Hovedstaden Denmark; 20. The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York New York USA展开收起
84
天
Therapeutic success and epidemiological failure in hematology
作者
Pierre Sujobert展开收起
作者单位
1. Hospices Civils de Lyon, Hôpital Lyon Sud, Service d'hématologie biologique Lyon France; 2. Faculté de médecine et de maïeutique Lyon Sud Charles Mérieux, Lymphoma Immunobiology Team, Université Claude Bernard Lyon 1 Oullins‐Pierre Bénite France展开收起
5
天
129
天
Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi‐LMC study
作者
Benjamin Podvin; Olivier Nibourel; Sandrine Hayette; Valérie Coiteux; Rathana Kim; Lucie Rigolot; Stéphanie Dulucq; Augustin Boudry; Geoffrey Pawlak; Wayne‐Corentin Lambert; Pascale Flandrin‐Gresta; Ivan Sloma; Christophe Roumier; Marie Balsat; Sandrine Loron; Chloé Li; Sandrine Geffroy; Jean‐Michel Cayuela; Françoise Huguet; François‐Xavier Mahon; Franck E. Nicolini; Delphine Réa; Claude Preudhomme; Nicolas Duployez; Catherine Roche‐Lestienne; Fi‐LMC group展开收起
作者单位
1. Laboratory of Hematology CHU Lille Lille France; 2. PERSTIM Lab, CRC Lille University of Lille, Inserm Lille France; 3. Institut Bergonié, Fi‐LMC Bordeaux France; 4. Laboratory of Hematology and Molecular Biology, CHU Lyon Sud Pierre‐Bénite France; 5. Hematology Department Huriez Hospital, CHU Lille Lille France; 6. Hematology Laboratory University Hospital Saint‐Louis, AP‐HP and EA3518, Université Paris Cité Paris France; 7. Université Paris Cité, UMR 1342, Institut de Recherche Saint‐Louis, Leukemia Institute Paris Saint‐Louis Paris France; 8. Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole Toulouse France; 9. Laboratory of Hematology, University Hospital of Bordeaux, INSERM U1312 France; 10. ULR 2694 Metrics, Centre Hospitalier Universitaire de Lille Université de Lille Lille France; 11. Laboratory of Hematology, University Hospital of Brest Brest France; 12. Hematology Laboratory University Hospital of Saint‐Etienne St Etienne France; 13. Hematology and Immunology Department AP‐HP Henri Mondor Créteil France; 14. Hematology Department CHU Lyon Sud Lyon France; 15. Hematology Department Hopital National d'Instruction des Armées Percy Clamart France; 16. Hematology Department Institut Universitaire du Cancer de Toulouse Toulouse France; 17. Institut Bergonié Bordeaux, Unicancer Aquitaine France; 18. INSERM Lyon France; 19. Hematology Department Centre Léon Bérard Lyon France; 20. Adult Hematology Department Saint Louis University Hospital Paris France; 21. Genetics Medical Institute, Hopital Jeanne de Flandre Lille France展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天